Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

326 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Melatonin reduces dimethylnitrosamine-induced liver fibrosis in rats.
Tahan V, Ozaras R, Canbakan B, Uzun H, Aydin S, Yildirim B, Aytekin H, Ozbay G, Mert A, Senturk H. Tahan V, et al. Among authors: yildirim b. J Pineal Res. 2004 Sep;37(2):78-84. doi: 10.1111/j.1600-079X.2004.00137.x. J Pineal Res. 2004. PMID: 15298665
Hepatitis C virus risk factors in the Turkish community.
Yildirim B, Tahan V, Ozaras R, Aytekin H, Mert A, Tabak F, Senturk H. Yildirim B, et al. Dig Dis Sci. 2005 Dec;50(12):2352-5. doi: 10.1007/s10620-005-3061-3. Dig Dis Sci. 2005. PMID: 16416188
Sexual transmission of HCV between spouses.
Tahan V, Karaca C, Yildirim B, Bozbas A, Ozaras R, Demir K, Avsar E, Mert A, Besisik F, Kaymakoglu S, Senturk H, Cakaloglu Y, Kalayci C, Okten A, Tozun N. Tahan V, et al. Among authors: yildirim b. Am J Gastroenterol. 2005 Apr;100(4):821-4. doi: 10.1111/j.1572-0241.2005.40879.x. Am J Gastroenterol. 2005. PMID: 15784025
Anti-HCV seroprevalence in chronic HCV patients' children in Turkey.
Tahan V, Yildirim B, Ture F, Giral A, Ozdogan O, Imeryuz N, Avsar E, Mert A, Senturk H, Kalayci C, Tozun N. Tahan V, et al. Among authors: yildirim b. J Clin Gastroenterol. 2004 Jan;38(1):90-1. doi: 10.1097/00004836-200401000-00025. J Clin Gastroenterol. 2004. PMID: 14679341 No abstract available.
Differences in nephrotoxicity risk and renal effects among anti-viral therapies against hepatitis B.
Koklu S, Gulsen MT, Tuna Y, Koklu H, Yuksel O, Demir M, Guner R, Dogan Z, Kucukazman M, Poyrazoglu OK, Biyik M, Ozturk NA, Aydogan T, Coban S, Kocaman O, Sapmaz F, Gokturk SH, Karaca C, Demirezer A, Tanoglu A, Yildirim B, Altinbas A, Atak BM, Cosar AM, Alkan E; Other collaborators. Koklu S, et al. Among authors: yildirim b. Aliment Pharmacol Ther. 2015 Feb;41(3):310-9. doi: 10.1111/apt.13036. Epub 2014 Dec 4. Aliment Pharmacol Ther. 2015. PMID: 25982037 Free article.
Long-term efficacy and safety of lamivudine, entecavir, and tenofovir for treatment of hepatitis B virus-related cirrhosis.
Köklü S, Tuna Y, Gülşen MT, Demir M, Köksal AŞ, Koçkar MC, Aygün C, Coban S, Ozdil K, Ataseven H, Akin E, Pürnak T, Yüksel I, Ataseven H, Ibiş M, Yildirim B, Nadir I, Küçükazman M, Akbal E, Yüksel O, Başar O, Alkan E, Baykal O. Köklü S, et al. Among authors: yildirim b. Clin Gastroenterol Hepatol. 2013 Jan;11(1):88-94. doi: 10.1016/j.cgh.2012.10.003. Epub 2012 Oct 9. Clin Gastroenterol Hepatol. 2013. PMID: 23063679
326 results